[1]
|
Majno, G. (1991) The Ancient Riddle of Sigma Eta Psi Iota Sigma (Sepsis). The Journal of Infectious Diseases, 163, 937-945. https://doi.org/10.1093/infdis/163.5.937
|
[2]
|
Singer, M., Deutschman, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. https://doi.org/10.1001/jama.2016.0287
|
[3]
|
Taylor Jr., F.B., Toh, C.H., Hoots, W.K., et al. (2001) Towards Defi-nition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation. Thrombosis and Haemostasis, 86, 1327-1330.
https://doi.org/10.1055/s-0037-1616068
|
[4]
|
Papageorgiou, C., Jourdi, G., Adjambri, E., et al. (2018) Dissemi-nated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies. Clinical and Applied Thrombosis/Hemostasis, 24, 8s-28s.
https://doi.org/10.1177/1076029618806424
|
[5]
|
Okabayashi, K., Wada, H., Ohta, S., et al. (2004) Hemostatic Markers and the Sepsis-Related Organ Failure Assessment Score in Patients with Disseminated Intravascular Coagula-tion in an Intensive Care Unit. American Journal of Hematology, 76, 225-229. https://doi.org/10.1002/ajh.20089
|
[6]
|
Anas, A.A., Wiersinga, W.J., de Vos, A.F., et al. (2010) Recent Insights into the Pathogenesis of Bacterial Sepsis. The Netherlands Journal of Medicine, 68, 147-152.
|
[7]
|
Schupp, T., Weidner, K., Rusnak, J., et al. (2022) Diagnostic and Prognostic Significance of the Prothrombin Time/ International Normalized Ratio in Sepsis and Septic Shock. Clinical and Applied Thrombosis/Hemostasis, 28.
https://doi.org/10.1177/10760296221137893
|
[8]
|
Rhee, C. and Klompas, M. (2020) Sepsis Trends: Increasing In-cidence and Decreasing Mortality, or Changing Denominator? Journal of Thoracic Disease, 12, S89-s100. https://doi.org/10.21037/jtd.2019.12.51
|
[9]
|
Vincent, J.L., Marshall, J.C., Namendys-Silva, S.A., et al. (2014) Assessment of the Worldwide Burden of Critical Illness: The Intensive Care over Nations (ICON) Audit. The Lancet Respiratory Medicine, 2, 380-386.
https://doi.org/10.1016/S2213-2600(14)70061-X
|
[10]
|
Rudd, K.E., Johnson, S.C., Agesa, K.M., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211.
https://doi.org/10.1016/S0140-6736(19)32989-7
|
[11]
|
Arefian, H., Heublein, S., Scherag, A., et al. (2017) Hospi-tal-Related Cost of Sepsis: A Systematic Review. Journal of Infection, 74, 107-117. https://doi.org/10.1016/j.jinf.2016.11.006
|
[12]
|
Levi, M. and van der Poll, T. (2017) Coagulation and Sepsis. Thrombosis Research, 149, 38-44.
https://doi.org/10.1016/j.thromres.2016.11.007
|
[13]
|
Manrique-Caballero, C.L., Del Rio-Pertuz, G. and Gomez, H. (2021) Sepsis-Associated Acute Kidney Injury. Critical Care Clinics, 37, 279-301. https://doi.org/10.1016/j.ccc.2020.11.010
|
[14]
|
Wu, Z., Deng, J., Zhou, H., et al. (2022) Programmed Cell Death in Sepsis Associated Acute Kidney Injury. Frontiers in Medicine, 9, Article ID: 883028. https://doi.org/10.3389/fmed.2022.883028
|
[15]
|
Liaw, P.C., Ito, T., Iba, T., et al. (2016) DAMP and DIC: The Role of Extracellular DNA and DNA-Binding Proteins in the Pathogenesis of DIC. Blood Reviews, 30, 257-261. https://doi.org/10.1016/j.blre.2015.12.004
|
[16]
|
Iba, T., Ito, T., Maruyama, I., et al. (2016) Potential Diagnostic Markers for Disseminated Intravascular Coagulation of Sepsis. Blood Reviews, 30, 149-155. https://doi.org/10.1016/j.blre.2015.10.002
|
[17]
|
Jiménez-Alcázar, M., Napirei, M., Panda, R., et al. (2015) Impaired DNase1-Mediated Degradation of Neutrophil Extracellular Traps Is Associated with Acute Thrombotic Microangiopa-thies. Journal of Thrombosis and Haemostasis, 13, 732-742. https://doi.org/10.1111/jth.12796
|
[18]
|
Iba, T., Levi, M. and Levy, J.H. (2020) Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. Seminars in Thrombosis and Hemostasis, 46, 89-95. https://doi.org/10.1055/s-0039-1694995
|
[19]
|
Mavrommatis, A.C., The-odoridis, T., Orfanidou, A., et al. (2000) Coagulation System and Platelets Are Fully Activated in Uncomplicated Sepsis. Critical Care Medicine, 28, 451-457.
https://doi.org/10.1097/00003246-200002000-00027
|
[20]
|
Iba, T. and Levy, J.H. (2019) Derangement of the En-dothelial Glycocalyx in Sepsis. Journal of Thrombosis and Haemostasis, 17, 283-294. https://doi.org/10.1111/jth.14371
|
[21]
|
Becker, B.F., Chappell, D., Bruegger, D., et al. (2010) Therapeutic Strategies Targeting the Endothelial Glycocalyx: Acute Deficits, but Great Potential. Cardiovascular Research, 87, 300-310. https://doi.org/10.1093/cvr/cvq137
|
[22]
|
Yamakawa, K., Umemura, Y., Hayakawa, M., et al. (2016) Benefit Profile of Anticoagulant Therapy in Sepsis: A Nationwide Multicentre Registry in Japan. Critical Care, 20, 229. https://doi.org/10.1186/s13054-016-1415-1
|
[23]
|
Umemura, Y., Yamakawa, K., Hayakawa, M., et al. (2018) Screening Itself for Disseminated Intravascular Coagulation May Reduce Mortality in Sepsis: A Nationwide Multicenter Registry in Japan. Thrombosis Research, 161, 60-66.
https://doi.org/10.1016/j.thromres.2017.11.023
|
[24]
|
Iba, T., Nisio, M.D., Levy, J.H., et al. (2017) New Criteria for Sepsis-Induced Coagulopathy (SIC) Following the Revised Sepsis Definition: A Retrospective Analysis of a Nationwide Survey. BMJ Open, 7, e017046.
https://doi.org/10.1136/bmjopen-2017-017046
|
[25]
|
Iba, T., Arakawa, M., Di Nisio, M., et al. (2020) Newly Pro-posed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality. Journal of Intensive Care Medicine, 35, 643-649. https://doi.org/10.1177/0885066618773679
|
[26]
|
Yamakawa, K., Yoshimura, J., Ito, T., et al. (2019) External Val-idation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis. Journal of Thrombosis and Haemo-stasis, 119, 203-212.
https://doi.org/10.1055/s-0038-1676610
|
[27]
|
Iba, T., Levy, J.H., Warkentin, T.E., et al. (2019) Diagnosis and Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. Journal of Thrombosis and Haemostasis, 17, 1989-1994.
https://doi.org/10.1111/jth.14578
|
[28]
|
Pierrakos, C. and Vincent, J.L. (2010) Sepsis Biomarkers: A Review. Criti-cal Care, 14, R15.
https://doi.org/10.1186/cc8872
|
[29]
|
Wada, H., Thachil, J., Di Nisio, M., et al. (2013) Guidance for Diagnosis and Treatment of DIC from Harmonization of the Recommendations from Three Guidelines. Journal of Thrombosis and Haemostasis.
https://doi.org/10.1111/jth.12155
|
[30]
|
Koyama, K., Madoiwa, S., Nunomiya, S., et al. (2014) Combination of Thrombin-Antithrombin Complex, Plasminogen Activator Inhibitor-1, and Protein C Activity for Early Identification of Severe Coagulopathy in Initial Phase of Sepsis: A Prospective Observational Study. Critical Care, 18, R13. https://doi.org/10.1186/cc13190
|
[31]
|
Akahoshi, T., Kaku, N., Shono, Y., et al. (2022) Impact of Antithrombin Ac-tivity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated In-travascular Coagulation. Clinical and Applied Thrombosis/Hemostasis, 28. https://doi.org/10.1177/10760296221135790
|
[32]
|
Huang, Z.F., Higuchi, D., Lasky, N., et al. (1997) Tissue Factor Pathway Inhibitor Gene Disruption Produces Intrauterine Lethality in Mice. Blood, 90, 944-951. https://doi.org/10.1182/blood.V90.3.944
|
[33]
|
Dong, J.F. (2005) Cleavage of Ultra-Large von Willebrand Factor by ADAMTS-13 under Flow Conditions. Journal of Thrombosis and Haemostasis, 3, 1710-1716. https://doi.org/10.1111/j.1538-7836.2005.01360.x
|
[34]
|
Brott, D.A., Katein, A., Thomas, H., et al. (2014) Evalua-tion of von Willebrand Factor and von Willebrand Factor Propeptide in Models of Vascular Endothelial Cell Activation, Perturbation, and/or Injury. Toxicologic Pathology, 42, 672-683. https://doi.org/10.1177/0192623313518664
|
[35]
|
Claus, R.A., Bockmeyer, C.L., Budde, U., et al. (2009) Variations in the Ratio between von Willebrand Factor and Its Cleaving Protease during Systemic Inflammation and Association with Severity and Prognosis of Organ Failure. Journal of Thrombosis and Haemostasis, 101, 239-247. https://doi.org/10.1160/TH08-03-0161
|
[36]
|
Andersson, U. and Tracey, K.J. (2011) HMGB1 Is a Therapeutic Tar-get for Sterile Inflammation and Infection. Annual Review of Immunology, 29, 139-162. https://doi.org/10.1146/annurev-immunol-030409-101323
|
[37]
|
Davis, R.P., Miller-Dorey, S. and Jenne, C.N. (2016) Platelets and Coagulation in Infection. Clinical & Translational Immunology, 5, e89. https://doi.org/10.1038/cti.2016.39
|
[38]
|
Wegrzyn, G., Walborn, A., Rondina, M., et al. (2021) Biomarkers of Platelet Activation and Their Prognostic Value in Patients with Sepsis-Associated Disseminated Intravascular Coag-ulopathy. Clinical and Applied Thrombosis/Hemos- tasis, 27. https://doi.org/10.1177/1076029620943300
|
[39]
|
Walborn, A., Hoppensteadt, D., Syed, D., et al. (2018) Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines. Clinical and Applied Thrombosis/Hemostasis, 24, 625-632.
https://doi.org/10.1177/1076029617709084
|
[40]
|
Yatabe, T., Inoue, S., Sakamoto, S., et al. (2018) The Anticoagu-lant Treatment for Sepsis Induced Disseminated Intravascular Coagulation; Network Meta-Analysis. Thrombosis Re-search, 171, 136-142.
https://doi.org/10.1016/j.thromres.2018.10.007
|
[41]
|
Levy, J.H., Sniecinski, R.M., Welsby, I.J., et al. (2016) An-tithrombin: Anti-Inflammatory Properties and Clinical Applications. Thrombosis and Haemostasis, 115, 712-728. https://doi.org/10.1160/TH15-08-0687
|
[42]
|
Endo, S. and Shimazaki, R. (2018) An Open-Label, Randomized, Phase 3 Study of the Efficacy and Safety of Antithrombin Gamma in Patients with Sepsis-Induced Disseminated Intra-vascular Coagulation Syndrome. Journal of Intensive Care, 6, 75. https://doi.org/10.1186/s40560-018-0339-z
|
[43]
|
Aikawa, N., Shimazaki, S., Yamamoto, Y., et al. (2011) Throm-bomodulin Alfa in the Treatment of Infectious Patients Complicated by Disseminated Intravascular Coagulation: Suba-nalysis from the Phase 3 Trial. Shock, 35, 349-354.
https://doi.org/10.1097/SHK.0b013e318204c019
|
[44]
|
Aoki, N., Matsuda, T., Saito, H., et al. (2002) A Compara-tive Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation. International Journal of Hematology, 75, 540-547. https://doi.org/10.1007/BF02982120
|
[45]
|
Liu, X.L., Wang, X.Z., Liu, X.X., et al. (2014) Low-Dose Heparin as Treatment for Early Disseminated Intravascular Coagulation during Sepsis: A Prospective Clinical Study. Experimental and Therapeutic Medicine, 7, 604-608.
https://doi.org/10.3892/etm.2013.1466
|
[46]
|
Vincent, J.L., Ramesh, M.K., Ernest, D., et al. (2013) A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular Coagulation. Critical Care Medicine, 41, 2069-2079.
https://doi.org/10.1097/CCM.0b013e31828e9b03
|
[47]
|
Vincent, J.L., Francois, B., Zabolotskikh, I., et al. (2019) Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA, 321, 1993-2002. https://doi.org/10.1001/jama.2019.5358
|